US09058V1035 - Common Stock
5.16 -0.16 (-3.01%)
Taking everything into account, BCRX scores 1 out of 10 in our technical rating. BCRX's overall performance in the market is below average. Also recent evolutions are not that positive. Both the medium and short term picture give negative signs.
BCRX has a poor technical rating and the quality of the setup is also only medium at the moment. We see reduced volatility while prices have been consolidating in the most recent period.
5 important resistance areas can be observed.
BIOCRYST PHARMACEUTICALS INC
NASDAQ:BCRX (11/28/2023, 9:38:05 AM)